Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Jandrain

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Diabetes Care|November 1, 1986
Anti-insulin antibodies and metabolic deterioration after interruption of continuous subcutaneous insulin infusionA J Scheen, P Henrivaux, B Jandrain, et al.
Revue Medicale De Liege|May 17, 2002
[Postprandial hyperglycemia. I. Physiopathology, clinical consequences and dietary management]A J Scheen, N Paquot, B Jandrain, et al.
Diabetes Care|November 1, 1987
U-100 insulin gives some protection against metabolic deterioration due to CSII interruptionA J Scheen, P Henrivaux, B Jandrain, et al.
Revue Medicale De Liege|August 29, 2001
[Multidisciplinary management of the obese patient: example from the Obesity Center at the University of Liege]A J Scheen, M Rorive, M Letiexhe, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|January 1, 1994
Relationships between metabolic clearance rate of insulin and body mass index in a female population ranging from anorexia nervosa to severe obesityM J Castillo, A J Scheen, B Jandrain, et al.
Diabetes Care|September 1, 1987
Prevention of metabolic alterations by insulin supplements administered either before or after 2-h nocturnal interruption of CSIIA J Scheen, P Henrivaux, B Jandrain, et al.
Diabetes Care|November 1, 1985
Lack of systematic metabolic alterations after a one-hour interruption of continuous subcutaneous insulin infusion in type I diabetic patientsA Scheen, P Henrivaux, B Jandrain, et al.
Revue Medicale De Liege|June 21, 2002
[Postprandial hyperglycemia. II. Pharmacological approaches]A J Scheen, M R Letiexhe, I Geronooz, et al.
Revue Medicale De Liege|September 6, 2008
[Blood glucose control and cardiovascular disease in patients with type 2 diabetes. Results of ACCORD, ADVANCE and VA-Diabetes trials]R P Radermecker, J C Philips, B Jandrain, et al.
Revue Medicale De Liege|November 13, 2001
[How I explore ... the different forms of sugar diabetes: clinical and biological differental diagnosis]A J Scheen, J C Philips, F H Luyckx, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Diabetes Care|November 1, 1986
Anti-insulin antibodies and metabolic deterioration after interruption of continuous subcutaneous insulin infusionA J Scheen, P Henrivaux, B Jandrain, et al.
Revue Medicale De Liege|May 17, 2002
[Postprandial hyperglycemia. I. Physiopathology, clinical consequences and dietary management]A J Scheen, N Paquot, B Jandrain, et al.
Diabetes Care|November 1, 1987
U-100 insulin gives some protection against metabolic deterioration due to CSII interruptionA J Scheen, P Henrivaux, B Jandrain, et al.
Revue Medicale De Liege|August 29, 2001
[Multidisciplinary management of the obese patient: example from the Obesity Center at the University of Liege]A J Scheen, M Rorive, M Letiexhe, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|January 1, 1994
Relationships between metabolic clearance rate of insulin and body mass index in a female population ranging from anorexia nervosa to severe obesityM J Castillo, A J Scheen, B Jandrain, et al.
Diabetes Care|September 1, 1987
Prevention of metabolic alterations by insulin supplements administered either before or after 2-h nocturnal interruption of CSIIA J Scheen, P Henrivaux, B Jandrain, et al.
Diabetes Care|November 1, 1985
Lack of systematic metabolic alterations after a one-hour interruption of continuous subcutaneous insulin infusion in type I diabetic patientsA Scheen, P Henrivaux, B Jandrain, et al.
Revue Medicale De Liege|June 21, 2002
[Postprandial hyperglycemia. II. Pharmacological approaches]A J Scheen, M R Letiexhe, I Geronooz, et al.
Revue Medicale De Liege|September 6, 2008
[Blood glucose control and cardiovascular disease in patients with type 2 diabetes. Results of ACCORD, ADVANCE and VA-Diabetes trials]R P Radermecker, J C Philips, B Jandrain, et al.
Revue Medicale De Liege|November 13, 2001
[How I explore ... the different forms of sugar diabetes: clinical and biological differental diagnosis]A J Scheen, J C Philips, F H Luyckx, et al.
Pageof 4